Lithium Administration and Monitoring

Introduction to Lithium Therapy

Serum concentrations should be determined twice per week during the acute phase and until levels and clinical condition stabilize, according to the American Academy of Sleep Medicine 1
Lithium toxicity is closely related to serum concentrations and can occur at doses close to therapeutic levels, necessitating careful monitoring, as reported by the American Academy of Sleep Medicine and Praxis Medical Insights 1, 2

Monitor GFR, electrolytes, and lithium levels every 6 months or more frequently if dose changes or patient becomes acutely unwell, as recommended by the American Journal of Kidney Diseases 3, 4
Lithium is nephrotoxic and may cause renal tubular dysfunction with prolonged use even at therapeutic levels, according to the American Journal of Kidney Diseases 3, 4
Avoid concomitant NSAIDs, which can decrease lithium clearance and increase toxicity risk, as warned by the American Journal of Kidney Diseases 3, 4, 5

Elderly patients are prone to develop neurotoxicity at higher lithium dosages, as reported by the American Family Physician 6, 7, 8
Based on animal studies, lithium may cause fetal harm; human studies suggest fetal harm but are insufficient to determine full risk, according to the American Academy of Sleep Medicine 1

The European Society of Cardiology notes that lithium use can lead to bradycardia, T-wave changes, and AV block, with effects on QT prolongation being divergent in reports 9
The European Heart Journal recommends caution with the use of antiarrhythmics and other medications affecting renal function when prescribing lithium 9

Administer the single daily lithium dose at bedtime or with the main meal to improve tolerability and absorption, as indicated by the American Journal of Respiratory and Critical Care Medicine. 10

The National Comprehensive Cancer Network (NCCN) advises that acetaminophen should not exceed a total of 4 g per day, and for chronic use the dose should be limited to ≤3 g per day to minimize the risk of hepatotoxicity. This recommendation is based on guideline consensus (moderate strength) 11.

The NCCN recommends that patients on lithium be instructed to review all over‑the‑counter medications and combination products for hidden acetaminophen content (e.g., cold/flu remedies, opioid‑acetaminophen formulations) to avoid inadvertent excess dosing. This guidance is derived from guideline consensus (moderate strength) 11.